Flamel Technologies S.A. Company Profile (NASDAQ:AVDL)

About Flamel Technologies S.A. (NASDAQ:AVDL)

Flamel Technologies S.A. logoFlamel Technologies S.A. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel's drug delivery platforms. The Company owns and develops drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company has two direct operating subsidiaries: Flamel US Holdings, Inc. and Flamel Irish Holdings, Ltd.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AVDL
  • CUSIP: N/A
  • Web: www.avadel.com
Capitalization:
  • Market Cap: $424.93 million
  • Outstanding Shares: 41,376,000
Average Prices:
  • 50 Day Moving Avg: $10.71
  • 200 Day Moving Avg: $10.08
  • 52 Week Range: $8.75 - $15.45
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 26.33
  • P/E Growth: 0.19
Sales & Book Value:
  • Annual Revenue: $166.54 million
  • Price / Sales: 2.55
  • Book Value: $1.43 per share
  • Price / Book: 7.18
Profitability:
  • EBIDTA: $58.4 million
  • Net Margins: -7.28%
  • Return on Equity: 14.49%
  • Return on Assets: 2.74%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 2.43%
  • Quick Ratio: 2.37%
Misc:
  • Average Volume: 192,700 shs.
  • Beta: 1.41
  • Short Ratio: 2.27
 
Frequently Asked Questions for Flamel Technologies S.A. (NASDAQ:AVDL)

What is Flamel Technologies S.A.'s stock symbol?

Flamel Technologies S.A. trades on the NASDAQ under the ticker symbol "AVDL."

How were Flamel Technologies S.A.'s earnings last quarter?

Flamel Technologies S.A. (NASDAQ:AVDL) issued its quarterly earnings results on Tuesday, May, 9th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.07 by $0.19. The business had revenue of $52.50 million for the quarter, compared to analyst estimates of $46.01 million. Flamel Technologies S.A. had a negative net margin of 7.28% and a positive return on equity of 14.49%. The company's revenue was up 45.0% compared to the same quarter last year. View Flamel Technologies S.A.'s Earnings History.

What guidance has Flamel Technologies S.A. issued on next quarter's earnings?

Flamel Technologies S.A. issued an update on its FY17 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of $0.30-0.45 for the period, compared to the Thomson Reuters consensus estimate of $0.21. The company issued revenue guidance of $170-185 million, compared to the consensus revenue estimate of $176.97 million.

Where is Flamel Technologies S.A.'s stock going? Where will Flamel Technologies S.A.'s stock price be in 2017?

2 equities research analysts have issued 1 year price objectives for Flamel Technologies S.A.'s shares. Their forecasts range from $16.00 to $16.00. On average, they expect Flamel Technologies S.A.'s share price to reach $16.00 in the next year. View Analyst Ratings for Flamel Technologies S.A..

Who are some of Flamel Technologies S.A.'s key competitors?

Who owns Flamel Technologies S.A. stock?

Flamel Technologies S.A.'s stock is owned by many different of institutional and retail investors. Top institutional shareholders include US Bancorp DE (0.03%) and Baldwin Brothers Inc. MA (0.02%). Company insiders that own Flamel Technologies S.A. stock include Craig R Stapleton, Francis Fildes, Guillaume Cerutti, Healthcare Master Fun Broadfin, Michael S Anderson, Phillandas T Thompson and Sandra L Hatten. View Institutional Ownership Trends for Flamel Technologies S.A..

How do I buy Flamel Technologies S.A. stock?

Shares of Flamel Technologies S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Flamel Technologies S.A.'s stock price today?

One share of Flamel Technologies S.A. stock can currently be purchased for approximately $10.27.


MarketBeat Community Rating for Flamel Technologies S.A. (NASDAQ AVDL)
Community Ranking:  3.4 out of 5 (  )
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  158
MarketBeat's community ratings are surveys of what our community members think about Flamel Technologies S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Flamel Technologies S.A. (NASDAQ:AVDL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.00 (55.79% upside)

Analysts' Ratings History for Flamel Technologies S.A. (NASDAQ:AVDL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/28/2016JMP SecuritiesReiterated RatingOutperform$16.00N/AView Rating Details
9/27/2016Leerink SwannReiterated RatingOutperform$16.00N/AView Rating Details
1/21/2016LaidlawLower Price TargetBuy$30.00 -> $25.00N/AView Rating Details
1/11/2016Roth CapitalLower Price TargetBuy$21.00 -> $17.50N/AView Rating Details
1/4/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Flamel Technologies S.A. (NASDAQ:AVDL)
Earnings by Quarter for Flamel Technologies S.A. (NASDAQ:AVDL)
Earnings History by Quarter for Flamel Technologies S.A. (NASDAQ AVDL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/20173/31/2017$0.07$0.26$46.01 million$52.50 millionViewListenView Earnings Details
3/7/201712/31/2016($0.03)$0.26$34.72 million$43.09 millionViewListenView Earnings Details
11/7/2016Q316($0.07)($0.08)$30.70 million$32.10 millionViewListenView Earnings Details
8/8/2016Q216$0.06($0.02)$32.80 million$38.90 millionViewN/AView Earnings Details
5/9/2016Q116$0.14$0.04$34.00 million$36.20 millionViewN/AView Earnings Details
3/10/2016Q415$0.09$0.32$44.69 million$43.40 millionViewListenView Earnings Details
11/12/2015Q215$0.23$0.28$50.33 million$47.30 millionViewListenView Earnings Details
7/30/2015Q2$0.40$0.34$62.50 million$49.80 millionViewListenView Earnings Details
5/15/2015Q115$0.18$0.34$37.37 million$32.73 millionViewListenView Earnings Details
3/19/2015Q414($0.22)($0.12)$13.10 million$3.00 millionViewN/AView Earnings Details
10/31/2014Q3 14($0.12)($0.16)$12.00 million$7.00 millionViewN/AView Earnings Details
7/29/2014Q214($0.08)($0.13)$9.92 million$8.10 millionViewN/AView Earnings Details
5/12/2014Q1 14($0.15)($0.15)$7.47 million$9.20 millionViewN/AView Earnings Details
10/31/2013Q313($0.20)($0.25)$6.47 million$5.60 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.27)($0.09)$5.35 million$5.50 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.33)($0.23)$6.11 million$5.10 millionViewN/AView Earnings Details
11/5/2012Q312($0.19)($0.26)$6.35 million$5.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Flamel Technologies S.A. (NASDAQ:AVDL)
2017 EPS Consensus Estimate: $0.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.06$0.07$0.07
Q2 20173$0.06$0.08$0.07
Q3 20173($0.03)$0.07$0.03
Q4 20173$0.00$0.07$0.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Flamel Technologies S.A. (NASDAQ:AVDL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Flamel Technologies S.A. (NASDAQ:AVDL)
Insider Ownership Percentage: 5.07%
Institutional Ownership Percentage: 70.43%
Insider Trades by Quarter for Flamel Technologies S.A. (NASDAQ:AVDL)
Institutional Ownership by Quarter for Flamel Technologies S.A. (NASDAQ:AVDL)
Insider Trades by Quarter for Flamel Technologies S.A. (NASDAQ:AVDL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/23/2017Healthcare Master Fun BroadfinMajor ShareholderSell261,000$10.68$2,787,480.00View SEC Filing  
6/15/2017Guillaume CeruttiDirectorSell26,560$10.46$277,817.60View SEC Filing  
5/22/2017Craig R StapletonDirectorBuy31,013$9.85$305,478.05View SEC Filing  
5/19/2017Michael S AndersonCEOBuy2,500$10.00$25,000.00View SEC Filing  
11/29/2016Craig R StapletonDirectorBuy20,000$10.79$215,800.00View SEC Filing  
11/21/2016Michael S. AndersonCEOBuy2,000$10.64$21,280.00View SEC Filing  
9/22/2016Francis FildesDirectorSell15,000$13.45$201,750.00View SEC Filing  
9/2/2016Michael S. AndersonCEOBuy2,000$14.12$28,240.00View SEC Filing  
9/1/2016Craig R StapletonDirectorBuy10,000$13.52$135,200.00View SEC Filing  
8/26/2016Craig R StapletonDirectorBuy20,000$13.76$275,200.00View SEC Filing  
8/22/2016Michael S. AndersonCEOBuy5,000$14.30$71,500.00View SEC Filing  
5/16/2016Craig R StapletonDirectorBuy27,228$9.21$250,769.88View SEC Filing  
5/12/2016Michael S AndersonCEOBuy5,000$8.84$44,200.00View SEC Filing  
3/22/2016Phillandas T ThompsonInsiderBuy10,000$11.10$111,000.00View SEC Filing  
3/18/2016Michael S AndersonCEOBuy5,000$11.04$55,200.00View SEC Filing  
3/18/2016Sandra L HattenVPBuy3,000$11.01$33,030.00View SEC Filing  
3/14/2016Craig R StapletonDirectorBuy100,000$10.39$1,039,000.00View SEC Filing  
3/14/2016Michael S AndersonInsiderBuy10,000$9.74$97,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Flamel Technologies S.A. (NASDAQ:AVDL)
Latest Headlines for Flamel Technologies S.A. (NASDAQ:AVDL)
Source:
DateHeadline
americanbankingnews.com logoHead-To-Head Analysis: Flamel Technologies (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - July 23 at 2:12 PM
americanbankingnews.com logoFlamel Technologies S.A. (NASDAQ:AVDL) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - July 21 at 7:16 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Report Second Quarter 2017 Results
finance.yahoo.com - July 20 at 5:42 PM
americanbankingnews.com logoComparing Flamel Technologies (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - July 19 at 2:34 PM
americanbankingnews.com logoFlamel Technologies (AVDL) & Acura Pharmaceuticals (ACUR) Financial Review
www.americanbankingnews.com - July 19 at 10:44 AM
americanbankingnews.com logoAcura Pharmaceuticals (ACUR) & Flamel Technologies (NASDAQ:AVDL) Financial Survey
www.americanbankingnews.com - July 19 at 12:14 AM
americanbankingnews.com logoContrasting Flamel Technologies (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - July 17 at 10:32 PM
americanbankingnews.com logoFlamel Technologies S.A. (AVDL) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - July 17 at 8:26 PM
americanbankingnews.com logoCritical Comparison: Flamel Technologies (AVDL) versus Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - July 16 at 8:12 PM
americanbankingnews.com logoHead to Head Analysis: Flamel Technologies (NASDAQ:AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - July 16 at 10:35 AM
americanbankingnews.com logoFinancial Review: Acura Pharmaceuticals (ACUR) vs. Flamel Technologies (AVDL)
www.americanbankingnews.com - July 16 at 7:46 AM
americanbankingnews.com logoCritical Survey: Acura Pharmaceuticals (ACUR) versus Flamel Technologies (NASDAQ:AVDL)
www.americanbankingnews.com - July 13 at 10:23 PM
finance.yahoo.com logoETFs with exposure to Avadel Pharmaceuticals Plc : July 13, 2017
finance.yahoo.com - July 13 at 4:59 PM
americanbankingnews.com logoAcura Pharmaceuticals (ACUR) versus Flamel Technologies (NASDAQ:AVDL) Financial Review
www.americanbankingnews.com - July 9 at 7:34 AM
americanbankingnews.com logoContrasting Acura Pharmaceuticals (ACUR) & Flamel Technologies (NASDAQ:AVDL)
www.americanbankingnews.com - July 7 at 12:24 PM
americanbankingnews.com logoHead to Head Analysis: Acura Pharmaceuticals (ACUR) & Flamel Technologies (NASDAQ:AVDL)
www.americanbankingnews.com - July 6 at 2:44 PM
americanbankingnews.com logoReviewing Acura Pharmaceuticals (ACUR) and Flamel Technologies (NASDAQ:AVDL)
www.americanbankingnews.com - July 5 at 6:36 PM
americanbankingnews.com logoFlamel Technologies S.A. (AVDL) Expected to Announce Quarterly Sales of $44.17 Million
www.americanbankingnews.com - July 5 at 9:39 AM
americanbankingnews.com logo Brokerages Expect Flamel Technologies S.A. (NASDAQ:AVDL) Will Post Earnings of $0.06 Per Share
www.americanbankingnews.com - July 3 at 10:20 PM
finance.yahoo.com logoETFs with exposure to Avadel Pharmaceuticals Plc : July 3, 2017
finance.yahoo.com - July 3 at 4:01 PM
americanbankingnews.com logoHealthcare Master Fun Broadfin Sells 261,000 Shares of Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Stock
www.americanbankingnews.com - June 26 at 7:16 PM
americanbankingnews.com logoFlamel Technologies S.A. (AVDL) Director Guillaume Cerutti Sells 26,560 Shares
www.americanbankingnews.com - June 19 at 7:35 PM
finance.yahoo.com logoETFs with exposure to Avadel Pharmaceuticals Plc : June 16, 2017
finance.yahoo.com - June 16 at 4:27 PM
finance.yahoo.com logoAvadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 10:16 AM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Bio-Path Holdings (BPTH) Head to Head Comparison
www.americanbankingnews.com - June 10 at 8:30 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Expected to Announce Quarterly Sales of $44.17 Million
www.americanbankingnews.com - June 9 at 12:38 PM
americanbankingnews.com logo$0.06 Earnings Per Share Expected for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) This Quarter
www.americanbankingnews.com - June 7 at 8:21 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Petmed Express (PETS) Head-To-Head Survey
www.americanbankingnews.com - June 5 at 12:47 PM
americanbankingnews.com logoMichael S. Anderson Acquires 2,500 Shares of Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Stock
www.americanbankingnews.com - May 22 at 8:14 PM
americanbankingnews.com logoInsider Buying: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Director Buys 31,013 Shares of Stock
www.americanbankingnews.com - May 22 at 7:46 PM
finance.yahoo.com logoAvadel Pharmaceuticals Supports the Narcolepsy Network's 5th Annual DREAM BIG Walk
finance.yahoo.com - May 17 at 12:13 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 12 at 7:42 PM
americanbankingnews.com logoSunTrust Banks Weighs in on Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's Q2 2017 Earnings (AVDL)
www.americanbankingnews.com - May 12 at 10:40 AM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Expected to Announce Earnings of $0.05 Per Share
www.americanbankingnews.com - May 11 at 10:10 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Lifted to Strong-Buy at Zacks Investment Research
www.americanbankingnews.com - May 9 at 10:28 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Updates FY17 Earnings Guidance
www.americanbankingnews.com - May 9 at 2:24 PM
americanbankingnews.com logoAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 9 at 1:38 PM
finance.yahoo.com logoInvestor Network: Avadel Pharmaceuticals plc to Host Earnings Call
finance.yahoo.com - May 9 at 9:04 AM
finance.yahoo.com logoAvadel Pharmaceuticals Reports First Quarter 2017 Results
finance.yahoo.com - May 9 at 9:04 AM
finance.yahoo.com logoAvadel posts 1Q profit
finance.yahoo.com - May 9 at 9:04 AM
finance.yahoo.com logoETFs with exposure to Avadel Pharmaceuticals Plc : May 3, 2017
finance.yahoo.com - May 3 at 3:48 PM
finance.yahoo.com logoAvadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q4, 2016 By the Numbers : May 2, 2017
finance.yahoo.com - May 2 at 3:47 PM
americanbankingnews.com logo$0.06 EPS Expected for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) This Quarter
www.americanbankingnews.com - April 21 at 8:31 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Report First Quarter 2017 Results
finance.yahoo.com - April 18 at 11:01 AM
americanbankingnews.com logoSunTrust Banks Weighs in on Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's FY2018 Earnings (AVDL)
www.americanbankingnews.com - April 3 at 12:52 PM
biz.yahoo.com logoAVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statement
biz.yahoo.com - March 31 at 8:53 PM
finance.yahoo.com logo4:04 pm Avadel Pharmaceuticals to reduce its headcount in France by approximately 50 people in 'an effort to align the Company's cost structure with its ongoing and future planned projects'
finance.yahoo.com - March 30 at 9:13 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Planned Reduction of French Workforce
finance.yahoo.com - March 30 at 4:10 PM
biz.yahoo.com logoAVADEL PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 28 at 8:46 PM
biz.yahoo.com logoAVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 17 at 4:22 PM

Social

Chart

Flamel Technologies S.A. (AVDL) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff